Anine Ottestad

Employment

• Oslo University Hospital Researcher
  2024 - Present

Education

• Norwegian University of Science and Technology PhD
  2019 - 2023
• Norwegian University of Science and Technology Master of Science
  2012 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer
  BMC Cancer 2023 DOI: 10.1186/s12885-023-11147-z
  +Save
• Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment
  Journal of Personalized Medicine 2022 DOI: 10.3390/jpm13010042
  +Save
• Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results
  Experimental and Molecular Pathology 2022 DOI: 10.1016/j.yexmp.2022.104771
  +Save
• The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study
  Cancers 2021 DOI: 10.3390/cancers13174294
  +Save
• Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA.
  Thomas L. Dunwell, Simon C. Dailey, Anine Larsen Ottestad +13 more
  Scientific reports 2021 DOI: 10.1038/s41598-021-82737-9
  +Save
• Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy.
  The journal of pathology. Clinical research 2021 DOI: 10.1002/cjp2.200
  +Save
• Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer
  Cancer Treatment and Research Communications 2021 DOI: 10.1016/j.ctarc.2021.100471
  +Save
• Abstract 3099: Ultra-deep next-generation sequencing of selected single genes for detecting circulating tumor DNA in lung cancer patients
  AACR Annual meeting 2020 2020 DOI: 10.1158/1538-7445.am2020-3099
  +Save
• The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients
  Experimental and Molecular Pathology 2020 DOI: 10.1016/j.yexmp.2019.104347
  +Save
• P2.09-03 Prognostic Value of Mutated KRAS in Circulating Tumor DNA Prior to Therapy in Patients with Lung Adenocarcinoma
  IASLC 2019 World Conference on Lung Cancer 2019 DOI: 10.1016/j.jtho.2019.08.1652
  +Save